SCHEMBL3925035

SCHEMBL3925035

Cc1ccc(CNS(=O)(=O)c2ccc(Br)cc2)cc1

nearest known ligand 0.71

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.71
CYP1A2 P05177 1/20 0.71
CYP3A4 P08684 1/20 0.71
ATM Q13315 1/20 0.71
CA9 Q16790 1/20 0.71
L3MBTL1 Q9Y468 1/20 0.71
ALDH1A1 P00352 5/20 0.68
LMNA P02545 4/20 0.67
SMN1; SMN2 Q16637 2/20 0.67
HTT P42858 1/20 0.67
CNR2 P34972 1/20 0.64
CYP19A1 P11511 2/20 0.64
EGFR P00533 1/20 0.60
ERBB2 P04626 1/20 0.60
MEN1 O00255 1/20 0.58
KMT2A Q03164 1/20 0.58
OPRK1 P41145 1/20 0.58
TP53 P04637 1/20 0.57
KDM4E B2RXH2 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5960052 1.00 CA12 (0.71) CA12CYP1A2CYP3A4ATMCA9
SCHEMBL25547142 0.91 CA12 (0.83) CA12CYP1A2CYP3A4ATMCA9
SCHEMBL17827613 0.85 CA12 (0.73) CA12CYP1A2CYP3A4ATMCA9
SCHEMBL29019309 0.84 ALDH1A1 (0.84) L3MBTL1ALDH1A1LMNASMN1; SMN2HTT
SCHEMBL28836818 0.83 CA1 (0.73) CA12CYP3A4CA9ALDH1A1CYP19A1
SCHEMBL27950177 0.83 CA12 (0.71) CA12CYP1A2CYP3A4ATMCA9
SCHEMBL5960116 0.83 MEN1 (0.73) CA12CYP1A2CYP3A4ATMCA9
SCHEMBL28113725 0.83 CA12 (0.73) CA12CYP1A2CYP3A4ATMCA9
SCHEMBL20946457 0.83 CYP19A1 (0.69) CA12CYP1A2CYP3A4ATMCA9
SCHEMBL26154030 0.83 CA12 (0.71) CA12CYP1A2CYP3A4ATMCA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2035372-A1 MODULATORS OF THE HISTAMINE H3-RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2009-03-18 EP disclosed
WO-2008005338-A1 MODULATORS OF THE HISTAMINE H3-RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2008-01-10 WO disclosed